Are all COX-2 inhibitors created equal?

被引：10

|

作者：

Chang, IJ ^{[1
]}

Harris, RC ^{[1
]}

机构：

[1] Vanderbilt Univ, Sch Med, Div Nephrol, Nashville, TN 37232 USA

来源：

HYPERTENSION | 2005年 / 45卷 / 02期

关键词：

D O I：

10.1161/01.HYP.0000153049.77150.d7

中图分类号：

R6 [外科学];

学科分类号：

1002 ; 100210 ;

摘要：

引用

收藏

页码：178 / 180

页数：3

相关论文

共 50 条

[41] Tempering the enthusiasm for COX-2 inhibitors
Nuovo, J
AMERICAN FAMILY PHYSICIAN, 2000, 61 (12) : 3560 - +
[42] The potential danger of COX-2 inhibitors
Norman, RJ
Wu, RJ
FERTILITY AND STERILITY, 2004, 81 (03) : 493 - 494
[43] COX-2 inhibitors for colorectal cancer
Douglas J. E. Elder
Christos Paraskeva
Nature Medicine, 1998, 4 : 392 - 393
[44] COX-2 inhibitors and cardiovascular risk
Funk, Colin D.
FitzGerald, Garret A.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2007, 50 (05) : 470 - 479
[45] COX-2 inhibitors in rheumatoid arthritis
Sundy J.S.
Current Rheumatology Reports, 2001, 3 (1) : 86 - 91
[46] Clinical aspects of COX-2 inhibitors
Emery, P
DRUGS OF TODAY, 1999, 35 (4-5) : 267 - 274
[47] Are COX-2 selective inhibitors nephrotoxic?
Dunn, MJ
AMERICAN JOURNAL OF KIDNEY DISEASES, 2000, 35 (05) : 976 - 977
[48] COX-2 inhibitors safety question
Dorey, E
CHEMISTRY & INDUSTRY, 2004, (20) : 6 - 6
[49] COX-2 inhibitors and their role in gynecology
Hayes, EC
Rock, JA
OBSTETRICAL & GYNECOLOGICAL SURVEY, 2002, 57 (11) : 768 - 780
[50] Cardiac risks with COX-2 inhibitors
Ashworth, Andrew J.
CANADIAN MEDICAL ASSOCIATION JOURNAL, 2007, 176 (04) : 489 - 492

← 1 2 3 4 5 →